| 2006 |
Crystal structures of human SMG5 and SMG6 PIN domains reveal that SMG6 has the canonical acidic triad required for RNase H-type nuclease activity and can degrade single-stranded RNA in vitro, whereas SMG5 lacks key catalytic residues and has no intrinsic nuclease activity. An SMG6 with an inactive PIN domain acts as a dominant-negative inhibitor of NMD in Drosophila. |
X-ray crystallography, in vitro ssRNA degradation assay, Drosophila dominant-negative genetics |
The EMBO journal |
High |
17053788
|
| 2003 |
Human SMG5 (hSmg5/7a) co-purifies with UPF1, UPF2, UPF3X, SMG1, and the catalytic subunit of protein phosphatase 2A (PP2A), and is required for dephosphorylation of UPF1 (but not UPF2), indicating SMG5 recruits PP2A to UPF1. SMG5 is predominantly cytoplasmic in HEK293T cells. |
Co-purification/co-immunoprecipitation, Western blot phosphatase assay, subcellular fractionation/Western blot |
RNA (New York, N.Y.) |
High |
12554878
|
| 2003 |
C. elegans SMG-5 interacts with SMG-7, SMG-2 (UPF1 ortholog), and both the structural (PR65) and catalytic subunits of PP2A, as determined by immunoprecipitation and yeast two-hybrid assays, directing PP2A to dephosphorylate SMG-2. |
Co-immunoprecipitation, yeast two-hybrid |
The EMBO journal |
High |
12554664
|
| 2013 |
Crystal structure of C. elegans SMG5-SMG7 complex shows their 14-3-3-like domains heterodimerize in an unusual perpendicular back-to-back orientation. Heterodimerization increases affinity of the complex for phosphorylated UPF1, and the degradative activity of the SMG5-SMG7 complex resides in SMG7. Structure-based mutations that disrupt the interaction impair NMD in human cells. |
X-ray crystallography, in vitro binding assays, structure-based mutagenesis, human cell NMD reporter assays |
Genes & development |
High |
23348841
|
| 2014 |
Using purified components reconstituted in vitro, the SMG5-SMG7 14-3-3-like heterodimer recognizes a short C-terminal phosphorylated segment of UPF1 (containing the last two Ser-Gln motifs) in a phospho-dependent manner, whereas SMG6 has both a weak phospho-dependent and a dominant phospho-independent interaction with UPF1 mediated by a low-complexity region bordering its 14-3-3-like domain and the UPF1 helicase domain and C-terminal tail. Crystal structure of SMG6 14-3-3-like domain confirms a phosphoserine-binding site. |
In vitro reconstitution with purified proteins, crystal structure, binding assays |
Nucleic acids research |
High |
25013172
|
| 2012 |
PNRC2 preferentially forms a complex with SMG5 (not SMG6 or SMG7); SMG5 bridges UPF1 (via phospho-dependent interaction) to PNRC2, which then connects to the decapping factor Dcp1a. Downregulation of PNRC2 abolishes the SMG5-Dcp1a interaction. Tethering assays place UPF1, SMG5, and PNRC2 at the same step in NMD. |
Co-immunoprecipitation, siRNA knockdown, tethering assay, microarray |
Nucleic acids research |
Medium |
23234702
|
| 2018 |
An interaction between SMG5 and PNRC2 was not detected physically or functionally in NMD reporters; instead, UPF1 directly interacts with PNRC2 and triggers 5'-3' exonucleolytic decay in tethering assays. SMG5-SMG7 complex interaction and its functional requirement for NMD was confirmed. PNRC2 knockdown does not affect NMD reporter RNA levels. |
Co-immunoprecipitation, tethering assay, siRNA knockdown, NMD reporter assay |
RNA (New York, N.Y.) |
Medium |
29348139
|
| 2021 |
Loss of the SMG5-SMG7 pathway also inactivates the SMG6 endonucleolytic branch, demonstrating that SMG5-SMG7 recruitment is required to authorize/license SMG6-mediated cleavage. Either SMG5 or SMG7 alone is sufficient to support SMG6 endonucleolysis and activate NMD, revealing SMG5 can substitute for SMG7. |
siRNA knockdown of SMG5/SMG7, transcriptome-wide RNA-seq, NMD reporter assays in human cells |
Nature communications |
High |
34172724
|
| 2018 |
In Drosophila, Smg5 is genetically essential for NMD activity, required for both SMG6-dependent endonucleolytic cleavage and an additional SMG6-independent degradation mechanism. Epistasis analysis shows Smg1 becomes essential for NMD when Smg5 function is partially compromised. |
Drosophila genetics, NMD reporter assays, epistasis analysis |
Genetics |
Medium |
29903866
|
| 2026 |
In C. elegans, the PIN domain of SMG-5, though catalytically inactive by canonical criteria, contains highly conserved residues essential for NMD. AlphaFold predicts a direct PIN-PIN interaction between SMG-5 and SMG-6, validated by in vitro pulldowns. Compensatory salt-bridge flip mutations confirm this interface is functionally required for SMG-6-mediated mRNA cleavage. |
AlphaFold structural prediction, in vitro pulldown, C. elegans genetic complementary mutagenesis, NMD reporter assays |
RNA (New York, N.Y.) |
Medium |
41638882
|
| 2026 |
AlphaFold models predict a high-confidence SMG5-SMG6 PIN domain interface forming a composite active site, where a conserved SMG5 aspartate (D893) completes the canonical tetrad required for PIN-domain catalysis. In vitro, SMG6 alone has weak endonuclease activity that is enhanced ~10-fold by the addition of the SMG5 PIN domain. Mutations at the predicted interface, RNA-binding sites, or active site abolish this composite endonuclease activity and impair cellular NMD. |
AlphaFold structural prediction, in vitro reconstituted endonuclease assay, mutagenesis, cell-based NMD assay |
Journal of molecular biology |
Medium |
41763597
|
| 2026 |
SMG5 and SMG6 interact via their PIN domains to form a composite PIN (cPIN) heterodimer with full endonuclease activity. Reconstituted SMG5-SMG6 cPIN heterodimers show high in vitro activity; SMG5 completes the SMG6 active site and substrate binding site. Mutations at their predicted interaction surfaces, RNA-binding sites, or active site attenuate or abolish cPIN activity in vitro and impair cellular NMD. |
Structural predictions (AlphaFold), biochemical in vitro reconstitution, mutagenesis, cell-based NMD analysis |
Nature communications |
High |
41714610
|
| 2025 |
Conditional knockout of Smg5 in mouse craniofacial neural crest cells causes abnormal accumulation of a PTC-containing Porcn transcript, leading to reduced Porcn protein and impaired Wnt5a/JNK signaling, resulting in hypoplastic mandibles, tongue mispositioning, and cleft palate. Wnt5a addition to SMG5-deficient CNC explants ameliorates cell death. |
Conditional knockout mouse model, transcriptome analysis, Western blot for Porcn, Wnt5a rescue in CNC explants |
iScience |
Medium |
40071146
|
| 2024 |
SMG5 knockout in mouse embryonic germ cells causes spermatogenesis failure (Sertoli cell-only phenotype) due to defective spermatogonial differentiation and maintenance. SMG5 loss leads to hyperactivation of the p38 MAPK signaling pathway causing widespread cell death during spermatogonial differentiation. |
Conditional knockout mouse model, transcriptome analysis, Western blot for p38 MAPK pathway components, histology |
FASEB journal |
Medium |
39704269
|
| 2024 |
Smg5 knockout mESCs are viable but show delayed differentiation. SMG5 loss causes upregulation of c-MYC protein (but not c-Myc mRNA), attributed to enhanced protein synthesis, and dysregulates alternative splicing of stem cell differentiation regulators. |
Conditional knockout mESCs, Western blot, polysome profiling inference, transcriptome/alternative splicing analysis |
Biomolecules |
Medium |
39199410
|
| 2025 |
Conditional knockout of Smg5 in oligodendrocyte lineage cells impairs oligodendrocyte differentiation and myelination due to failure to degrade PTC-containing Hnrnpl variant transcripts. Excess HNRNPL disrupts alternative splicing of myelin-associated genes Mag and Nfasc. |
Conditional knockout mouse model, RNA analysis, Western blot, electron microscopy of myelin, motor function assays |
The Journal of neuroscience |
Medium |
40930975
|